College of Life Science and Bioengineering, Beijing University of Technology, Beijing 100124, China.
Bioorg Med Chem Lett. 2010 Sep 15;20(18):5469-71. doi: 10.1016/j.bmcl.2010.07.087. Epub 2010 Jul 25.
(E)-N-[3-(4-cinnamoylpiperazin-1-yl)propyl]-3,4-dihydroxybenzamide and (E)-N-[3-(4-cinnamoylpiperazin-1-yl)propyl]-3,4,5-trihydroxybenzamide were designed and synthesized as potential HIV-1 integrase inhibitors and evaluated their inhibition to the strand transfer process of HIV-1 integrase. The result indicates that 3,4,5-trihydroxylated aromatic derivatives exhibit good inhibition to HIV-1 integrase, however, corresponding 3,4-dihydroxylated aromatic derivatives appear little inhibition of HIV-1 integrase.
(E)-N-[3-(4-肉桂酰基哌嗪-1-基)丙基]-3,4-二羟基苯甲酰胺和(E)-N-[3-(4-肉桂酰基哌嗪-1-基)丙基]-3,4,5-三羟基苯甲酰胺被设计和合成作为潜在的 HIV-1 整合酶抑制剂,并评估它们对 HIV-1 整合酶的链转移过程的抑制作用。结果表明,3,4,5-三羟基芳基衍生物对 HIV-1 整合酶表现出良好的抑制作用,然而,相应的 3,4-二羟基芳基衍生物对 HIV-1 整合酶几乎没有抑制作用。